Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Betaine is a major osmolyte, also important in methyl group metabolism. Concentrations of betaine, its metabolite dimethylglycine and analog trimethylamine-N-oxide (TMAO) in blood are cardiovascular risk markers. Diabetes disturbs betaine: does diabetes alter associations between betaine-related measures and cardiovascular risk? METHODS: Plasma samples were collected from 475 subjects four months after discharge following an acute coronary admission. Death (n = 81), secondary acute MI (n = 87), admission for heart failure (n = 85), unstable angina (n = 72) and all cardiovascular events (n = 283) were recorded (median follow-up: 1804 days). RESULTS: High and low metabolite concentrations were defined as top or bottom quintile of the total cohort. In subjects with diabetes (n = 79), high plasma betaine was associated with increased frequencies of events; significantly for heart failure, hazard ratio 3.1 (1.2-8.2) and all cardiovascular events, HR 2.8 (1.4-5.5). In subjects without diabetes (n = 396), low plasma betaine was associated with events; significantly for secondary myocardial infarction, HR 2.1 (1.2-3.6), unstable angina, HR 2.3 (1.3-4.0), and all cardiovascular events, HR 1.4 (1.0-1.9). In diabetes, high TMAO was a marker of all outcomes, HR 2.7 (1.1-7.1) for death, 4.0 (1.6-9.8) for myocardial infarction, 4.6 (2.0-10.7) for heart failure, 9.1 (2.8-29.7) for unstable angina and 2.0 (1.1-3.6) for all cardiovascular events. In subjects without diabetes TMAO was only significant for death, HR 2.7 (1.6-4.8) and heart failure, HR 1.9 (1.1-3.4). Adding the estimated glomerular filtration rate to Cox regression models tended to increase the apparent risks associated with low betaine. CONCLUSIONS: Elevated plasma betaine concentration is a marker of cardiovascular risk in diabetes; conversely low plasma betaine concentrations indicate increased risk in the absence of diabetes. We speculate that the difference reflects control of osmolyte retention in tissues. Elevated plasma TMAO is a strong risk marker in diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, elevated plasma TMAO levels have been found in people at risk of CVD. These patients usually show greater concentrations of the TMAO precursors too.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In this context, it is thought that TMAO could serve as a biomarker in humans to predict prevalence of CVD and increased incidence of major adverse cardiovascular events (MACE), such as myocardial infarction, stroke and even death [7,14,52,53,54,55].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Numerous recent case–control and longitudinal studies have shown a striking association between trimethylamine N‐oxide (TMAO) levels and cardiovascular disease risks in a variety of cohorts.1, 2, 3, 4, 5, 6, 7, 8, 9, 10”
From Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB (2016) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“In humans, recent clinical studies evidence a positive correlation between elevated plasma levels of TMAO and an increased risk for major adverse cardiovascular events.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“we also performed a sensitivity analysis for the 18 data when we replaced RRs for all‐cause mortality in these publications7, 10, 22, 26; the pooled RR was 1.69 (95% CI, 1.52, 1.89; P<0.001; P heterogeneity=0.6; I2=0%).”
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 7×
“These are not only the TMAO that is found in many fish [38], but also other substituted trimethylamines such as choline [23, 24] and carnitine [40].”
BackgroundResultInfluentialIntestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Vicari, R., Frey, M. J., Lakkis, N., Neumann, F.-J., Robertson, D. H., DeLucca, P. T., DiBattiste, P. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442501 · Cited by 2,103
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa060900 · Cited by 1,729
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442 · cited 1×
“Although supplementation with folate, vitamin B12 and vitamin B6 is effective in lowering plasma homocysteine levels, these supplements have not been observed to have any effect on the risk of secondary coronary events [15–17].”
BackgroundCraig, S. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.539 · Cited by 1,062
Wang, Z., Tang, W. H. W., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., Levison, B. S., Fan, Y., Wu, Y., & Hazen, S. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu002 · Cited by 559
Albert, C. M., Cook, N. R., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E., & Manson, J. E. (2008) · JAMA · doi:10.1001/jama.299.17.2027 · Cited by 511
The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism
Lever, M., & Slow, S. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.03.009 · Cited by 460
Self-citationde Ruijter, W., Westendorp, R. G. J., Assendelft, W. J. J., den Elzen, W. P. J., de Craen, A. J. M., le Cessie, S., & Gussekloo, J. (2009) · BMJ · doi:10.1136/bmj.a3083 · Cited by 339
Bain, M. A., Faull, R., Fornasini, G., Milne, R. W., & Evans, A. M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk056 · Cited by 282 · cited 2×
“Plasma TMAO has previously been shown to be a marker of renal disease [25, 26], and is a biomarker of fish consumption [38].”
BackgroundBetaine: a key modulator of one-carbon metabolism and homocysteine status
Ueland, P. M., Holm, P. I., & Hustad, S. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.187 · Cited by 265
Konstantinova, S. V., Tell, G. S., Vollset, S. E., Nygård, O., Bleie, Ø., & Ueland, P. M. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.5.914 · Cited by 240
Bell, J. D., Lee, J. A., Lee, H. A., Sadler, P. J., Wilkie, D. R., & Woodham, R. H. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90046-c · Cited by 147 · cited 2×
“Plasma TMAO has previously been shown to be a marker of renal disease [25, 26], and is a biomarker of fish consumption [38].”
BackgroundHyperhomocysteinaemia: A Critical Review of Old and New Aspects
Herrmann, W., Herrmann, M., & Obeid, R. (2006) · Current Drug Metabolism · doi:10.2174/138920007779315008 · Cited by 110
Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations
McGregor, D. O. R., Dellow, W. J., Lever, M., George, P. M., Robson, R. A., & Chambers, S. T. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00743.x · Cited by 110
Self-citationSvingen, G. F. T., Ueland, P. M., Pedersen, E. R., Schartum-Hansen, H., Seifert, R., Ebbing, M., Løland, K. H., Tell, G. S., & Nygard, O. K. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301714 · Cited by 107
Plasma dependent and independent accumulation of betaine in male and female rat tissues
Slow, S., Lever, M., Chambers, S., & George, P. (2009) · Physiological Research · doi:10.33549/physiolres.931569 · Cited by 102
Self-citationTrimethylaminuria: causes and diagnosis of a socially distressing condition.
Mackay, R. J., McEntyre, C. J., Henderson, C., Lever, M., & George, P. M. (2011) · Europe PMC (PubMed Central) · Cited by 96
Self-citationBetaine and Secondary Events in an Acute Coronary Syndrome Cohort
Lever, M., George, P. M., Elmslie, J. L., Atkinson, W., Slow, S., Molyneux, S. L., Troughton, R. W., Richards, M., FRAMPTON, C. M. A., & Chambers, S. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037883 · Cited by 86
Self-citationEffects of diabetes and insulin on betaine-homocysteineS-methyltransferase expression in rat liver
Ratnam, S., Wijekoon, E. P., Hall, B., Garrow, T. A., Brosnan, M. E., & Brosnan, J. T. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00498.2005 · Cited by 80
Schwab, U., Törrönen, A., Meririnne, E., Saarinen, M., Alfthan, G., Aro, A., & Uusitupa, M. I. J. (2006) · Journal of Nutrition · doi:10.1093/jn/136.1.34 · Cited by 79
Dellow, W. J., Chambers, S. T., Lever, M., Lunt, H., & Robson, R. A. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00115-6 · Cited by 78
Self-citationAbnormal glycine betaine content of the blood and urine of diabetic and renal patients
Lever, M., Sizeland, P., Bason, L. M., Hayman, C. M., Robson, R. A., & Chambers, S. T. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90090-6 · Cited by 75
Self-citationShort and long-term variation of plasma glycine betaine concentrations in humans
Lever, M., Sizeland, P., FRAMPTON, C. M. A., & Chambers, S. T. (2003) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.11.004 · Cited by 72
Self-citationHomocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic
Lever, M., George, P. M., Dellow, W. J., Scott, R. S., & Chambers, S. T. (2004) · Metabolism · doi:10.1016/j.metabol.2004.07.007 · Cited by 71
Self-citationOsmotic regulation of hepatic betaine metabolism
Hoffmann, L., Brauers, G., Gehrmann, T., Häussinger, D., Mayatepek, E., Schliess, F., & Schwahn, B. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00332.2012 · Cited by 69
Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes
Ellis, K. L., Newton‐Cheh, C., Wang, T. J., Frampton, C. M., Doughty, R. N., WHALLEY, G. A., Ellis, C., Skelton, L., Davis, N., Yandle, T. G., et al. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.01.010 · Cited by 64
Self-citationPlasma Lipids and Betaine Are Related in an Acute Coronary Syndrome Cohort
Lever, M., George, P. M., Atkinson, W., Molyneux, S. L., Elmslie, J. L., Slow, S., Richards, M., & Chambers, S. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021666 · Cited by 61
Self-citationDietary and supplementary betaine: Effects on betaine and homocysteine concentrations in males
Atkinson, W., Slow, S., Elmslie, J. L., Lever, M., Chambers, S. T., & George, P. M. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.01.004 · Cited by 56
Self-citationAssessment of Urinary Betaine as a Marker of Diabetes Mellitus in Cardiovascular Patients
Schartum-Hansen, H., Ueland, P. M., Pedersen, E. R., Meyer, K., Ebbing, M., Bleie, Ø., Svingen, G. F. T., Seifert, R., Vikse, B. E., & Nygård, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069454 · Cited by 43
Ueland, P. M., & Clarke, R. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.085480 · Cited by 39
Lever, M., Slow, S., McGregor, D. O. R., Dellow, W. J., George, P. M., & Chambers, S. T. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-34 · Cited by 38
Self-citationEisert, R., Oftedal, O., Lever, M., Ramdohr, S., Breier, B., & Barrell, G. (2005) · Marine Ecology Progress Series · doi:10.3354/meps300213 · Cited by 35
Self-citationSeparation of cationic aracyl derivatives of betaines and related compounds
Storer, M., McEntyre, C. J., & Lever, M. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.11.123 · Cited by 29
Self-citationStorer, M., & Lever, M. (2005) · Analytica Chimica Acta · doi:10.1016/j.aca.2005.10.060 · Cited by 20
Self-citationPlasma and urine betaine and dimethylglycine variation in healthy young male subjects
Lever, M., Atkinson, W., Slow, S., Chambers, S. T., & George, P. M. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.02.001 · Cited by 19
Self-citationRelease of osmolytes induced by phagocytosis and hormones in rat liver
Wettstein, M., Peters-Regehr, T., Kubitz, R., Fischer, R., Holneicher, C., Mönnighoff, I., & Häussinger, D. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.2.g227 · Cited by 18
Inter- and intra-individual variations in normal urinary glycine betaine excretion
Lever, M., Atkinson, W., Sizeland, P., Chambers, S. T., & George, P. M. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.10.029 · Cited by 17
Self-citationLever, M., Storer, M., Lewis, J. G., George, P. M., & Chambers, S. T. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-9911 · Cited by 8
Self-citationLever, M., Storer, M., Lewis, J. G., George, P. M., & Chambers, S. T. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-9910 · Cited by 7
Self-citationLever, M., Storer, M., Lewis, J. G., George, P. M., & Chambers, S. T. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0844 · Cited by 4
Self-citation
Cited by
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
“…of TMAO have been shown in multiple distinct clinical studies and cohorts to be associated with CVD risks (Wang et al., 2011; Tang et al., 2013; Lever et al., 2014; Wang et al., 2014a; Tang et al., 2015 ; Trøseid et al., 2015), and targetted suppression of microbial TMA/TMAO production has…”
Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317
“…TMAO levels are associated with risks for both prevalent atherosclerotic heart disease and incident major adverse cardiac events in multiple independent cohorts (Koeth et al., 2013; Lever et al., 2014; Mente et al., 2015; Tang et al., 2013, 2014; Trøseid et al., 2015; Wang et al., 2011, 2014b).”
BackgroundGut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Seldin, M. M., Meng, Y., Qi, H., Zhu, W., Wang, Z., Hazen, S. L., Lusis, A. J., & Shih, D. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002767 · Cited by 911
Janeiro, M., Ramírez, M., Milagro, F., Martínez, J., & Solas, M. (2018) · Nutrients · doi:10.3390/nu10101398 · Cited by 631
“, (2014) [53] found that high levels of betaine were associated with cardiovascular risk (CVR) only in diabetic patients.”
Background
Metadata
- Authors
- Lever, M., George, P. M., Slow, S., Bellamy, D., Young, J. M., Ho, M., McEntyre, C. J., Elmslie, J. L., Atkinson, W., Molyneux, S. L., Troughton, R. W., Frampton, C. M., Richards, A. M., & Chambers, S. T.
- Affiliations
- Canterbury Health Laboratories (NZ)
- University of Otago (NZ)
- Corresponding author
- Lever, Michael
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-10
- Volume
- 9
- Issue
- 12
- Pages
- e114969
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4262445
- OpenAlex
- W2045387428
- Cited by
- 223
- References
- 43
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 15 · 2023: 14 · 2022: 29 · 2021: 25 · 2020: 32 · 2019: 19 · 2018: 12 · 2017: 25 · 2016: 21 · 2015: 13
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Maurice and Phyllis Paykel Trust
- Health Research Council of New Zealand (02/152)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- betaine, trimethylamine N-oxide, dimethylglycine, cardiovascular risk markers, diabetes mellitus, heart failure, myocardial infarction, unstable angina, cardiovascular mortality, acute coronary syndrome, estimated glomerular filtration rate, plasma metabolites, methyl group metabolism, osmolytes, risk stratification, risk prediction model
- MeSH terms
- Aged, Aged, 80 and over, Betaine, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Male, Methylamines, Middle Aged, Risk Factors, Biomarkers, Proportional Hazards Models, Case-Control Studies, Kaplan-Meier Estimate, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.